LLY

Eli Lilly & Co
D

LLY

Arincen80/100B

Eli Lilly & Co P/E ratio

Eli Lilly & Co's P/E ratio is 46.56: its share price of 1,438.17 over its earnings per share of 30.89 over the last twelve months.

Today
46.56
Forward P/E, next 12 months
29.81
PEG ratio
1.80
Median, 5 years
55.41
Low, 5 years
33.10
High, 5 years
148.63

P/E ratio = price ÷ EPS (last 12 months) = 1,438.17 ÷ 30.89 = 46.56

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is Eli Lilly & Co's P/E high compared with its own history?

Eli Lilly & Co's P/E of 46.6 is below the middle of its 5-year range (33.1 to 148.6, median 55.4). Analysts expect slower growth than in recent years, so the low P/E may be deserved.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal yearPeriod endingP/E ratioForward P/EMarket capNet income
FY2027 · Estimate31 Dec 202728.62———
FY2026 · Estimate31 Dec 202640.67———
Today46.5629.811.35T27.58B
FY202531 Dec 202546.7630.40965.06B20.64B
FY202431 Dec 202465.6532.72695.27B10.59B
FY202331 Dec 2023100.0445.58524.27B5.24B
FY202231 Dec 202255.6658.71347.61B6.24B
FY202131 Dec 202147.1936.16263.42B5.58B
FY202031 Dec 202026.0820.76161.51B6.19B
FY201931 Dec 201915.1317.83125.85B8.32B
FY201831 Dec 201836.8019.90118.93B3.23B
FY201731 Dec 2017—15.1988.85B-204.10M
FY201631 Dec 201629.5817.4580.97B2.74B
FY201531 Dec 201538.6723.7993.13B2.41B
FY201431 Dec 201432.0520.0776.62B2.39B
FY201331 Dec 201312.1618.6856.96B4.68B
FY201231 Dec 201213.8314.0556.55B4.09B
FY201131 Dec 201110.6514.1746.29B4.35B
FY201031 Dec 20107.648.4238.75B5.07B
FY200931 Dec 20099.068.5839.22B4.33B
FY200831 Dec 2008—11.6144.08B-2.07B
FY200731 Dec 200719.7113.2258.22B2.95B
FY200631 Dec 200621.2716.3456.62B2.66B
FY200531 Dec 200531.0918.6261.55B1.98B
FY200431 Dec 200433.9820.5661.51B1.81B
FY200331 Dec 200329.5526.0575.67B2.56B
FY200231 Dec 200225.3026.0268.51B2.71B
FY200131 Dec 200130.4430.8084.63B2.78B
FY200031 Dec 200032.8834.47100.55B3.06B
FY199931 Dec 199926.6025.6872.38B2.72B
FY199831 Dec 199846.3139.3397.49B2.11B
FY199731 Dec 1997—37.2476.67B-385.10M
FY199631 Dec 199626.2022.9639.92B1.52B
FY199531 Dec 199513.96—31.98B2.29B
FY199431 Dec 199414.75—18.97B1.29B
FY199331 Dec 199336.28—17.82B491.10M
FY199231 Dec 199221.32—17.65B827.60M
FY199131 Dec 199118.48—24.29B1.31B
FY199031 Dec 199018.68—21.06B1.13B
FY198931 Dec 198921.41—20.12B939.50M
FY198831 Dec 198815.96—12.14B761.00M
FY198731 Dec 198717.41—11.21B643.70M
FY198631 Dec 198618.20—10.16B558.20M
FY198531 Dec 198514.83—7.68B517.60M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

See also:Market cap,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Eli Lilly & Co's P/E ratio

Source: Financial Modeling Prep